about
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches.Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.Metabotropic glutamate receptor 5: a target for migraine therapy.Dopamine: what's new in migraine?Efficacy and mechanism of anticonvulsant drugs in migraine.A novel translational animal model of trigeminal autonomic cephalalgias.Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: a Fos protein study.Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activation.Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine.Evidence for orexinergic mechanisms in migraine.Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.Topiramate inhibits trigeminovascular activation: an intravital microscopy study.The trigeminovascular system does not require a peripheral sensory input to be activated--migraine is a central disorder. Focus on 'Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system'.TRPV1 receptor blockade is ineffective in different in vivo models of migraine.Inhibition of trigeminovascular dural nociceptive afferents by Ca(2+)-activated K(+) (MaxiK/BK(Ca)) channel opening.Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex.Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents.The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels.The role of histamine in dural vessel dilation.GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil.Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system.Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura.Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms.Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons.
P50
Q34372828-1B41B1BD-E41B-42AE-BE9D-C8B6CB9073FFQ37165496-E5F4A031-A79F-4711-832E-78595C6FDEC6Q37208487-C80CFF1D-BA84-4C52-853E-CDFD2DC3A7F8Q37694248-BB60315F-EB6D-45C9-8769-84D62DD04964Q38185096-73C260B0-C07B-4D0A-9E4D-28EFCCE045D3Q38323935-61F99815-54A1-4CB7-8DAB-F2E93EE5A89AQ38443387-428D56BD-A58E-4EA3-B8E1-E73E50E3773FQ38610565-8137D091-B74B-443C-80DF-61896BCC12ADQ40454917-7E323A6E-568A-4520-B70D-1F64943D4515Q41758695-3B198561-8079-4D48-9334-55D80005FA80Q41974492-C37A458F-9D08-40C6-95F2-83B945941609Q42217288-78AEEB05-1166-456A-B80E-4295FF4A322AQ42499075-624C409F-A0B2-429C-9FEA-D49A6B1B1A22Q42679624-D23C343F-CDD1-47C3-80AC-A9EC2440DE12Q42959612-29F2392C-70E9-4970-B1C3-4D9F7A4623C2Q43298111-BE733DC9-B08C-4C39-9DD5-4BBAFDB52274Q43720937-0505D8CB-1E08-4273-A1A9-124E94F1DD49Q44158827-8428CFAC-6B2F-477C-A6D2-F04D06DAF473Q44212266-FFE2F1D6-6B6F-4DC2-BECC-65A5CBC9AB81Q44933392-6E0EA742-0B6B-4D13-96EB-17EEA33DB900Q45218202-70541891-3596-4E21-AE2B-80BB8AB751EAQ46628363-E91C384F-0DD3-4FDE-8525-1FBB6DDDD910Q46828449-C3B7CD5F-025F-4847-8345-F08E292FE87FQ48405359-28AD57F1-0886-497F-955C-C52382CA0B6D
P50
name
Simon Akerman
@en
Simon Akerman
@nl
type
label
Simon Akerman
@en
Simon Akerman
@nl
prefLabel
Simon Akerman
@en
Simon Akerman
@nl